Terms: = Brain cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Diagnosis
18 results:
1. Harnessing the potential of nanoengineered siRNAs carriers for target responsive glioma therapy: Recent progress and future opportunities.
Ahirwar K; Kumar A; Srivastava N; Saraf SA; Shukla R
Int J Biol Macromol; 2024 May; 266(Pt 1):131048. PubMed ID: 38522697
[TBL] [Abstract] [Full Text] [Related]
2. Driver gene KRAS aggravates cancer-associated stroke outcomes.
Yan H; Sasaki T; Gon Y; Nishiyama K; Kanki H; Mochizuki H
Thromb Res; 2024 Jan; 233():55-68. PubMed ID: 38029547
[TBL] [Abstract] [Full Text] [Related]
3. Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer.
Urbaniak A; Reed MR; Heflin B; Gaydos J; Piña-Oviedo S; Jędrzejczyk M; Klejborowska G; Stępczyńska N; Chambers TC; Tackett AJ; Rodriguez A; Huczyński A; Eoff RL; MacNicol AM
Biomed Pharmacother; 2022 Sep; 153():113440. PubMed ID: 36076555
[TBL] [Abstract] [Full Text] [Related]
4. Transcription Factors with Targeting Potential in Gliomas.
Giannopoulou AI; Kanakoglou DS; Piperi C
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409080
[TBL] [Abstract] [Full Text] [Related]
5. Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation.
Cardona AF; Jaramillo-Velásquez D; Ruiz-Patiño A; Polo C; Jiménez E; Hakim F; Gómez D; Ramón JF; Cifuentes H; Mejía JA; Salguero F; Ordoñez C; Muñoz Á; Bermúdez S; Useche N; Pineda D; Ricaurte L; Zatarain-Barrón ZL; Rodríguez J; Avila J; Rojas L; Jaller E; Sotelo C; Garcia-Robledo JE; Santoyo N; Rolfo C; Rosell R; Arrieta O
J Neurooncol; 2021 Sep; 154(3):353-364. PubMed ID: 34498213
[TBL] [Abstract] [Full Text] [Related]
6. Dual activating FGFR1 mutations in pediatric pilomyxoid astrocytoma.
Fomchenko EI; Reeves BC; Sullivan W; Marks AM; Huttner A; Kahle KT; Erson-Omay EZ
Mol Genet Genomic Med; 2021 Feb; 9(2):e1597. PubMed ID: 33448156
[TBL] [Abstract] [Full Text] [Related]
7. The potential oncogenic role of the RAS-like GTP-binding gene RIT1 in glioblastoma.
Khalil A; Nemer G
Cancer Biomark; 2020; 29(4):509-519. PubMed ID: 32831193
[TBL] [Abstract] [Full Text] [Related]
8. Expression and prognostic role of E2F transcription factors in high-grade glioma.
Yu H; Li Z; Wang M
CNS Neurosci Ther; 2020 Jul; 26(7):741-753. PubMed ID: 32064771
[TBL] [Abstract] [Full Text] [Related]
9. Necroptotic astrocytes contribute to maintaining stemness of disseminated medulloblastoma through CCL2 secretion.
Liu H; Sun Y; O'Brien JA; Franco-Barraza J; Qi X; Yuan H; Jin W; Zhang J; Gu C; Zhao Z; Yu C; Feng S; Yu X
Neuro Oncol; 2020 May; 22(5):625-638. PubMed ID: 31729527
[TBL] [Abstract] [Full Text] [Related]
10. A novel infram deletion in MSH6 gene in glioma: Conversation on MSH6 mutations in brain tumors.
Deris Zayeri Z; Tahmasebi Birgani M; Mohammadi Asl J; Kashipazha D; Hajjari M
J Cell Physiol; 2019 Jul; 234(7):11092-11102. PubMed ID: 30478893
[TBL] [Abstract] [Full Text] [Related]
11. Pharmacologic IL-6Rα inhibition in cholangiocarcinoma promotes cancer cell growth and survival.
Kleinegger F; Hofer E; Wodlej C; Golob-Schwarzl N; Birkl-Toeglhofer AM; Stallinger A; Petzold J; Orlova A; Krassnig S; Reihs R; Niedrist T; Mangge H; Park YN; Thalhammer M; Aigelsreiter A; Lax S; Garbers C; Fickert P; Rose-John S; Moriggl R; Rinner B; Haybaeck J
Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):308-321. PubMed ID: 30419338
[TBL] [Abstract] [Full Text] [Related]
12. stat3 labels a subpopulation of reactive astrocytes required for brain metastasis.
Priego N; Zhu L; Monteiro C; Mulders M; Wasilewski D; Bindeman W; Doglio L; Martínez L; Martínez-Saez E; Ramón Y Cajal S; Megías D; Hernández-Encinas E; Blanco-Aparicio C; Martínez L; Zarzuela E; Muñoz J; Fustero-Torre C; Piñeiro-Yáñez E; Hernández-Laín A; Bertero L; Poli V; Sanchez-Martinez M; Menendez JA; Soffietti R; Bosch-Barrera J; Valiente M
Nat Med; 2018 Jul; 24(7):1024-1035. PubMed ID: 29892069
[TBL] [Abstract] [Full Text] [Related]
13. EGFRvIII-Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival.
Roos A; Dhruv HD; Peng S; Inge LJ; Tuncali S; Pineda M; Millard N; Mayo Z; Eschbacher JM; Loftus JC; Winkles JA; Tran NL
Mol Cancer Res; 2018 Jul; 16(7):1185-1195. PubMed ID: 29724813
[TBL] [Abstract] [Full Text] [Related]
14. Tocotrienols: The promising analogues of vitamin E for cancer therapeutics.
Sailo BL; Banik K; Padmavathi G; Javadi M; Bordoloi D; Kunnumakkara AB
Pharmacol Res; 2018 Apr; 130():259-272. PubMed ID: 29496592
[TBL] [Abstract] [Full Text] [Related]
15. Pilot Study of Whole Blood MicroRNAs as Potential Tools for Diffuse Low-Grade Gliomas Detection.
Gozé C; Reynes C; Forestier L; Sabatier R; Duffau H
Cell Mol Neurobiol; 2018 Apr; 38(3):715-725. PubMed ID: 28815332
[TBL] [Abstract] [Full Text] [Related]
16. Signal transducer and activator of transcription 3 (stat3) promoter methylation and expression in pituitary adenoma.
Valiulyte I; Steponaitis G; Skiriute D; Tamasauskas A; Vaitkiene P
BMC Med Genet; 2017 Jul; 18(1):72. PubMed ID: 28709401
[TBL] [Abstract] [Full Text] [Related]
17. Exosomal Annexin II Promotes Angiogenesis and Breast cancer Metastasis.
Maji S; Chaudhary P; Akopova I; Nguyen PM; Hare RJ; Gryczynski I; Vishwanatha JK
Mol Cancer Res; 2017 Jan; 15(1):93-105. PubMed ID: 27760843
[TBL] [Abstract] [Full Text] [Related]
18. Association between Prediagnostic Allergy-Related Serum Cytokines and Glioma.
Schwartzbaum J; Seweryn M; Holloman C; Harris R; Handelman SK; Rempala GA; Huang RP; Burkholder B; Brandemihl A; Kallberg H; Johannesen TB; Ahlbom A; Feychting M; Grimsrud TK
PLoS One; 2015; 10(9):e0137503. PubMed ID: 26352148
[TBL] [Abstract] [Full Text] [Related]
